MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MANNATECH INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)
Close on Oct 19, 2026
- Market cap
- $16.87M
- P/E (TTM)
- –
- Dividend yield
- –
MANNATECH INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $105.50M | $104.50M | $106.00M | $108.60M | $111.20M | – | $115.90M | – | – | – | – | – | 98.3% | -5.1% |
| Product and Service, Other [Member] | $1.50M | $1.50M | $1.60M | $1.50M | $1.40M | – | $1.50M | – | – | – | – | – | 1.4% | +7.1% |
| Associate Service Fees [Member] | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | – | $500.00K | – | – | – | – | – | 0.4% | 0.0% |
| Consolidated pack sales and associate fees | – | – | – | – | – | $3.70M | $4.10M | $4.30M | $4.20M | $4.60M | $5.60M | $6.10M | – | – |
| Other | – | – | – | – | – | $1.40M | $1.50M | $1.50M | $1.60M | $1.40M | $1.10M | $900.00K | – | – |
| Product sales | – | – | – | – | – | $109.90M | $112.30M | $115.70M | $116.60M | $121.30M | $125.30M | $126.60M | – | – |
By region
From the segment and revenue-disaggregation notes of Mannatech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.